CAW
GILD icon

Cornerstone Advisors (Washington)’s Gilead Sciences GILD Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$536K Sell
8,488
-994
-10% -$68.9K 0.06% 41
2020
Q2 		$730K Buy
9,482
+442
+5% +$33.9K 0.08% 27
2020
Q1 		$676K Buy
9,040
+4,737
+110% +$327K 0.09% 25
2019
Q4 		$280K Buy
4,303
+98
+2% +$6.38K 0.03% 71
2019
Q3 		$267K Buy
4,205
+104
+3% +$6.8K 0.04% 64
2019
Q2 		$277K Buy
4,101
+388
+10% +$25.5K 0.03% 105
2019
Q1 		$241K Buy
3,713
+548
+17% +$36.4K 0.02% 116
2018
Q4 		$198K Buy
3,165
+45
+1% +$3.15K 0.04% 122
2018
Q3 		$241K Buy
3,120
+178
+6% +$13.4K 0.16% 103
2018
Q2 		$208K Sell
2,942
-2,601
-47% -$184K 0.14% 118
2018
Q1 		$418K Buy
5,543
+379
+7% +$30.1K 0.28% 55
2017
Q4 		$370K Hold
5,164
– – 0.25% 57
2017
Q3 		$418K Buy
5,164
+461
+10% +$35.3K 0.29% 53
2017
Q2 		$333K Buy
4,703
+2,209
+89% +$147K 0.19% 61
2017
Q1 		$169K Sell
2,494
-2,662
-52% -$187K 0.09% 119
2016
Q4 		$369K Buy
5,156
+411
+9% +$30.5K 0.31% 46
2016
Q3 		$375K Buy
4,745
+4,261
+880% +$346K 0.32% 40
2016
Q2 		$40K Buy
484
+51
+12% +$4.53K 0.04% 178
2016
Q1 		$40K Sell
433
-18
-4% -$1.62K 0.04% 181
2015
Q4 		$46K Buy
451
+18
+4% +$1.87K 0.05% 190
2015
Q3 		$43K Sell
433
-13
-3% -$1.44K 0.04% 194
2015
Q2 		$52K Buy
446
+87
+24% +$9.51K 0.04% 166
2015
Q1 		$35K Hold
359
– – 0.03% 225
2014
Q4 		$34K Buy
359
+161
+81% +$16.7K 0.02% 218
2014
Q3 		$21K Sell
198
-27
-12% -$2.64K 0.02% 126
2014
Q2 		$19K Hold
225
– – 0.02% 150
2014
Q1 		$16K Buy
225
+46
+26% +$3.61K 0.02% 152
2013
Q4 		$13K Buy
179
+17
+10% +$1.18K 0.02% 126
2013
Q3 		$10K Buy
162
+12
+8% +$717 0.02% 136
2013
Q2 		$8K Buy
+150
New +$7.82K 0.02% 96

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cornerstone Advisors (Washington)'s GILD Position: Q3 2020 in Review

Cornerstone Advisors (Washington) reduced its Gilead Sciences (GILD) stake by 10% in Q3 2020, selling an estimated $68.9K and leaving 8,488 shares worth $536K. The position accounts for 0.06% of the portfolio, ranked #41.

Cornerstone Advisors (Washington) first reported a position in GILD in Q2 2013 and has held it in 30 quarters since. The position peaked at $730K in Q2 2020. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Cornerstone Advisors (Washington) held 8,488 shares of Gilead Sciences worth $536K as of Q3 2020.
  • Cornerstone Advisors (Washington) sold 994 Gilead Sciences shares in Q3 2020, an estimated $68.9K.
  • Gilead Sciences made up 0.06% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #41 holding.
  • Cornerstone Advisors (Washington) first reported a position in Gilead Sciences in Q2 2013 and has held it in 30 quarters since.
  • Cornerstone Advisors (Washington)'s Gilead Sciences position peaked at $730K in Q2 2020.
  • 1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.